{"id":21789,"date":"2023-09-24T14:41:27","date_gmt":"2023-09-24T14:41:27","guid":{"rendered":"https:\/\/microloannexus.com\/investing\/yields-up-to-6-in-healthcare-staples\/"},"modified":"2023-09-24T14:41:28","modified_gmt":"2023-09-24T14:41:28","slug":"yields-up-to-6-in-healthcare-staples","status":"publish","type":"post","link":"https:\/\/microloannexus.com\/?p=21789","title":{"rendered":"Yields Up To 6% In Healthcare, Staples"},"content":{"rendered":"
\n

Worried that the Federal Reserve is driving our economy off a cliff?<\/p>\n

I\u2019ve got two words for you:<\/p>\n

Drugs<\/em> \u2018n diapers<\/em>.<\/p>\n

Actually, I forgot one. Dividends<\/em>.<\/p>\n

These companies are about as recession-resistant as they come. Let\u2019s start with drugs because, well, it\u2019s always<\/em> a bull market on prescription spend in America:<\/p>\n

While some of us are popping pills, others are changing diapers. (Or using<\/em> them\u2014we don\u2019t judge!)<\/p>\n

Without naming names we can see that someone<\/em> is making consistent deposits. The trajectory of diaper spend is a one-way trade, too:<\/p>\n

<\/fbs-ad><\/p>\n

Let\u2019s start on the changing table with a 2.5% payer and work our way up. Or front to back. (Sorry, couldn\u2019t resist the girl dad<\/em> joke.)<\/p>\n

Procter & Gamble
\n
\n PG
\n <\/fbs-ticker> (PG)<\/strong><\/p>\n

Dividend Yield:<\/strong> 2.5%<\/p>\n

The diaper business is extremely concentrated among just a few players. In fact, nine of the top 10 brands by revenue worldwide<\/em> are owned by just two companies:<\/p>\n

Procter & Gamble (PG)<\/strong> and Kimberly-Clark
\n
\n KMB
\n <\/fbs-ticker> (KMB)<\/strong><\/p>\n

The former is responsible for Pampers and Luvs, as well as relative newcomer All Good, launched in 2020 specifically for sale in Walmart
\n
\n WMT
\n <\/fbs-ticker> (WMT)<\/strong> stores.<\/p>\n

Of course, Procter & Gamble offers many more pivotal consumer staples products, including as Head & Shoulders and Herbal Essences shampoos, Crest and Oral-B dental products, Olay and Secret personal care brands, Tide and Gain laundry detergents, Cascade and Mr. Clean home care, Bounty paper towels, and Charmin toilet paper. (And those are just some<\/em> of P&G\u2019s biggest brands.)<\/p>\n

P&G is one of the longest-standing Dividend Aristocrats, boasting 67 consecutive payout hikes (and 133 consecutive years of dividends paid). That includes a 3% increase announced earlier this year.<\/p>\n

Usually, when a company has improved dividends for as long as P&G has, dividend hikes tend to get a little chintzy thanks to slowing profit growth and a typically high payout ratio. But P&G is spryer than you\u2019d think. Only a little more than 60% of profits are going toward the dividend\u2014high, but not so high that the company is capable of only token raises going forward\u2014and indeed, dividend growth has been at least respectable over the past decade.<\/p>\n

The big downside? Headline yield. Procter & Gamble delivers a mere 2.5% right now, which is less than many plain-vanilla dividend ETFs.<\/p>\n

That\u2019s not to say PG is a lousy long-term holding\u2014far from it. But if investors do<\/em> flock toward income amid an economic stumble, P&G probably won\u2019t be a top beneficiary.<\/p>\n

Kimberly-Clark (KMB)<\/strong><\/p>\n

Dividend Yield: <\/strong>3.5%<\/p>\n

While not ideal, Kimberly-Clark\u2019s (KMB)<\/strong> 3%-plus dividend is at least another step in the right direction.<\/p>\n

Kimberly-Clark is responsible for Huggies, Pull-Ups, KleenBeb\u00e9, Goodnites, DryNites and Little Swimmers diapers. And like P&G, it\u2019s a broader consumer staples giant, boasting massive brands including Kleenex tissues, Cottonelle and Scott toilet paper, Viva paper towels, Kotex feminine care and Depend adult care.<\/p>\n

KMB shares have been both volatile and unproductive for years. While shares quickly rebounded from their COVID drop and even eked out some gains, Kimberly-Clark\u2019s stock is virtually flat from the start of 2020\u2014even when including dividends. Consumer staples as a whole have underperformed the market in that time, but not by nearly so much.<\/p>\n

Among KMB\u2019s issues have been high input costs\u2014indeed, margins still remain lower than their pre-COVID levels. Also hobbled is K-C Professional, which took a hit from the mass exodus from offices.<\/p>\n

It\u2019s a mixed bag on the income front, too. On the one hand, Kimberly-Clark is another longtime Aristocrat that has delivered more than half a century of uninterrupted dividend growth, and it delivers a better yield than P&G. However, its dividend growth has been slightly less robust over the past decade or so, and its payout ratio is higher, at 72%. That\u2019s not to say KMB\u2019s dividend will suddenly implode, but the potential for dividend growth isn\u2019t quite as high.<\/p>\n

Pfizer
\n
\n PFE
\n <\/fbs-ticker> (PFE)<\/strong><\/p>\n

Dividend Yield:<\/strong> 4.8%<\/p>\n

We can find more substantial, attractive yields in the healthcare space right now, starting with pharmaceutical giant Pfizer (PFE)<\/strong>.<\/p>\n

Pfizer, of course, gained some acclaim during the pandemic for creating one of the primary COVID-19 vaccines as well as antiviral Paxlovid. But it boasts dozens of pharmaceuticals and other treatments, including Eliquis (blood clots), Prevnar (pneumococcal disease), Vyndaqel (cardiomyopathy), Xeljanz (arthritis) and Ibrance (breast cancer).<\/p>\n

Like with many pharma companies, Pfizer constantly has to refresh its pipeline to make up for revenues that are about to fall off the patent cliff. In PFE\u2019s case, it has to make up for $17 billion worth of revenues that it\u2019ll lose between 2025 through 2030. Fortunately, Pfizer has a deep pipeline\u2014over the next 18 months alone, it\u2019s expected to launch some 19 products or indications, 15 of which are from its own R&D. Pfizer has been plenty acquisitive, too, however, snapping up Global Blood Therapeutics and Biohaven, and it\u2019s currently in the process of buying Seagen.<\/p>\n

While Pfizer has a rich dividend history of more than 80 years\u2019 worth of consecutive payouts, its dividend increase<\/em> track record isn\u2019t quite as robust\u2014it has hiked for a little more than a decade following its 2009 cut alongside its $68 billion buyout of Wyeth.<\/p>\n

That said, the payout is up about 70% over the past decade or so. And Pfizer has a lot of room to raise\u2014only a bit more than 40% of profits go to fund the dividend right now.<\/p>\n

Viatris (VTRS)<\/strong><\/p>\n

Dividend Yield:<\/strong> 4.9%<\/p>\n

Pfizer also has a connection to another high-yielding pharma name: Viatris (VTRS)<\/strong>, which was formed in 2020 when Mylan
\n MYL
\n <\/fbs-ticker> merged with Upjohn, Pfizer\u2019s off-patent branded and generic established medicines business.<\/p>\n

The Viatris portfolio includes a number of juggernauts that, even if off-patent, still generate considerable revenues. That includes Lipitor (cholesterol), Norvasc (blood pressure), Lyrica (nerve and muscle pain), EpiPen (allergic reactions), Viagra (erectile dysfunction), Zoloft (depression) and Xanax (anxiety).<\/p>\n

Despite this lineup, VTRS has been in a deep funk ever since its formation.<\/p>\n

This is a company that\u2019s still trying to find itself. Right now, it\u2019s trying to divest non-core assets and low-margin businesses while investing in higher-margin businesses. Recent moves including buying up Tyrvaya (dry eye disease) and selling its biosimilars portfolio.<\/p>\n

Because it was formed by merger, Viatris\u2019s dividend history is difficult to splice, and thus not helpful for understanding where it\u2019s going. Worryingly, however, the company\u2019s last dividend hike was a 9% bump in January 2022\u2014so it\u2019s long overdue for a raise.<\/p>\n

It\u2019s not that VTRS can\u2019t afford it\u2014dividends account for just 30% or so of profits. But the company has a strong focus on paying down debt and buying back shares, which is a distraction from appeasing income-minded folks like us.<\/p>\n

Organon
\n
\n OGN
\n <\/fbs-ticker> (OGN)<\/strong><\/p>\n

Dividend Yield:<\/strong> 5.9%<\/p>\n

We\u2019re getting a fairly juicy yield with Organon (OGN)<\/strong>, the spinoff of several Merck (MRK) <\/strong>businesses.<\/p>\n

Specifically, Organon is made up of Merck legacy products (62% of revenues), women\u2019s health treatments (27%), biosimilars (8%) and other drugs (3%). Treatments include Singulair (allergies\/asthma), Nasonex (allergies), Atozet (cholesterol), NuvaRing (birth control) and Nexplanon (birth control).<\/p>\n

And like with Viatris, Organon has had a difficult go of things.<\/p>\n

Organon\u2019s woes are fairly straightforward: Like with Viatris, Organon was a dumping ground for (among other things) older treatments, which allowed Pfizer and Merck, respectively, to focus on growth. Revenues for many of these products are unsurprisingly flat or in decline.<\/p>\n

So, why would we buy stocks like OGN?<\/p>\n

Well, the dividends, for one\u2014Organon, at a nearly 6% yield, pays out 4x what the market does. Also, Organon has a decent business case. This is a diversified pharmaceutical portfolio with a specialization in women\u2019s health, which is expected to be a $50 billion market by 2025. Also, OGN is largely expected to deploy capital into M&A to rejuvenate its growth.<\/p>\n

Brett Owens is chief investment strategist for <\/em>Contrarian Outlook<\/em>. For more great income ideas, get your free copy his latest special report: <\/em>Your Early Retirement Portfolio: Huge Dividends\u2014Every Month\u2014Forever.<\/p>\n

Disclosure: none<\/em><\/p>\n<\/div>\n

Read the full article here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Worried that the Federal Reserve is driving our economy off a cliff? I\u2019ve got two words for you: Drugs \u2018n diapers. Actually, I forgot one. Dividends. These companies are about as recession-resistant as they come. Let\u2019s start with drugs because, well, it\u2019s always a bull market on prescription spend in America: While some of us<\/p>\n","protected":false},"author":1,"featured_media":21790,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[49],"tags":[],"class_list":{"0":"post-21789","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-investing"},"yoast_head":"\nYields Up To 6% In Healthcare, Staples | Micro Loan Nexus<\/title>\n<meta name=\"description\" content=\"Worried that the Federal Reserve is driving our economy off a cliff? I\u2019ve got two words for you: Drugs \u2018n diapers. Actually, I forgot one. Dividends.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/microloannexus.com\/?p=21789\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Yields Up To 6% In Healthcare, Staples | Micro Loan Nexus\" \/>\n<meta property=\"og:description\" content=\"Worried that the Federal Reserve is driving our economy off a cliff? I\u2019ve got two words for you: Drugs \u2018n diapers. Actually, I forgot one. Dividends.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/microloannexus.com\/?p=21789\" \/>\n<meta property=\"og:site_name\" content=\"Micro Loan Nexus\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-24T14:41:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-24T14:41:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/09\/1695566488_0x0.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"798\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/microloannexus.com\/?p=21789#article\",\"isPartOf\":{\"@id\":\"https:\/\/microloannexus.com\/?p=21789\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/microloannexus.com\/#\/schema\/person\/e2d3b62d35ac325be68540d68dc6660a\"},\"headline\":\"Yields Up To 6% In Healthcare, Staples\",\"datePublished\":\"2023-09-24T14:41:27+00:00\",\"dateModified\":\"2023-09-24T14:41:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/microloannexus.com\/?p=21789\"},\"wordCount\":1351,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/microloannexus.com\/#organization\"},\"articleSection\":[\"Investing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/microloannexus.com\/?p=21789#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/microloannexus.com\/?p=21789\",\"url\":\"https:\/\/microloannexus.com\/?p=21789\",\"name\":\"Yields Up To 6% In Healthcare, Staples | Micro Loan Nexus\",\"isPartOf\":{\"@id\":\"https:\/\/microloannexus.com\/#website\"},\"datePublished\":\"2023-09-24T14:41:27+00:00\",\"dateModified\":\"2023-09-24T14:41:28+00:00\",\"description\":\"Worried that the Federal Reserve is driving our economy off a cliff? I\u2019ve got two words for you: Drugs \u2018n diapers. Actually, I forgot one. Dividends.\",\"breadcrumb\":{\"@id\":\"https:\/\/microloannexus.com\/?p=21789#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/microloannexus.com\/?p=21789\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/microloannexus.com\/?p=21789#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/microloannexus.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Yields Up To 6% In Healthcare, Staples\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/microloannexus.com\/#website\",\"url\":\"https:\/\/microloannexus.com\/\",\"name\":\"Solutions For Real\",\"description\":\"Latest Finance News and Updates\",\"publisher\":{\"@id\":\"https:\/\/microloannexus.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/microloannexus.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/microloannexus.com\/#organization\",\"name\":\"Solutions For Real\",\"url\":\"https:\/\/microloannexus.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/microloannexus.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/sf-logo-1.png\",\"contentUrl\":\"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/sf-logo-1.png\",\"width\":690,\"height\":64,\"caption\":\"Solutions For Real\"},\"image\":{\"@id\":\"https:\/\/microloannexus.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/microloannexus.com\/#\/schema\/person\/e2d3b62d35ac325be68540d68dc6660a\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/microloannexus.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1691264579-96x96.png\",\"contentUrl\":\"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1691264579-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/microloannexus.com\"],\"url\":\"https:\/\/microloannexus.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Yields Up To 6% In Healthcare, Staples | Micro Loan Nexus","description":"Worried that the Federal Reserve is driving our economy off a cliff? I\u2019ve got two words for you: Drugs \u2018n diapers. Actually, I forgot one. Dividends.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/microloannexus.com\/?p=21789","og_locale":"en_US","og_type":"article","og_title":"Yields Up To 6% In Healthcare, Staples | Micro Loan Nexus","og_description":"Worried that the Federal Reserve is driving our economy off a cliff? I\u2019ve got two words for you: Drugs \u2018n diapers. Actually, I forgot one. Dividends.","og_url":"https:\/\/microloannexus.com\/?p=21789","og_site_name":"Micro Loan Nexus","article_published_time":"2023-09-24T14:41:27+00:00","article_modified_time":"2023-09-24T14:41:28+00:00","og_image":[{"width":1200,"height":798,"url":"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/09\/1695566488_0x0.jpg","type":"image\/jpeg"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/microloannexus.com\/?p=21789#article","isPartOf":{"@id":"https:\/\/microloannexus.com\/?p=21789"},"author":{"name":"News Room","@id":"https:\/\/microloannexus.com\/#\/schema\/person\/e2d3b62d35ac325be68540d68dc6660a"},"headline":"Yields Up To 6% In Healthcare, Staples","datePublished":"2023-09-24T14:41:27+00:00","dateModified":"2023-09-24T14:41:28+00:00","mainEntityOfPage":{"@id":"https:\/\/microloannexus.com\/?p=21789"},"wordCount":1351,"commentCount":0,"publisher":{"@id":"https:\/\/microloannexus.com\/#organization"},"articleSection":["Investing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/microloannexus.com\/?p=21789#respond"]}]},{"@type":"WebPage","@id":"https:\/\/microloannexus.com\/?p=21789","url":"https:\/\/microloannexus.com\/?p=21789","name":"Yields Up To 6% In Healthcare, Staples | Micro Loan Nexus","isPartOf":{"@id":"https:\/\/microloannexus.com\/#website"},"datePublished":"2023-09-24T14:41:27+00:00","dateModified":"2023-09-24T14:41:28+00:00","description":"Worried that the Federal Reserve is driving our economy off a cliff? I\u2019ve got two words for you: Drugs \u2018n diapers. Actually, I forgot one. Dividends.","breadcrumb":{"@id":"https:\/\/microloannexus.com\/?p=21789#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/microloannexus.com\/?p=21789"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/microloannexus.com\/?p=21789#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/microloannexus.com\/"},{"@type":"ListItem","position":2,"name":"Yields Up To 6% In Healthcare, Staples"}]},{"@type":"WebSite","@id":"https:\/\/microloannexus.com\/#website","url":"https:\/\/microloannexus.com\/","name":"Solutions For Real","description":"Latest Finance News and Updates","publisher":{"@id":"https:\/\/microloannexus.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/microloannexus.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/microloannexus.com\/#organization","name":"Solutions For Real","url":"https:\/\/microloannexus.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/microloannexus.com\/#\/schema\/logo\/image\/","url":"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/sf-logo-1.png","contentUrl":"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/sf-logo-1.png","width":690,"height":64,"caption":"Solutions For Real"},"image":{"@id":"https:\/\/microloannexus.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/microloannexus.com\/#\/schema\/person\/e2d3b62d35ac325be68540d68dc6660a","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/microloannexus.com\/#\/schema\/person\/image\/","url":"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1691264579-96x96.png","contentUrl":"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1691264579-96x96.png","caption":"News Room"},"sameAs":["https:\/\/microloannexus.com"],"url":"https:\/\/microloannexus.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/posts\/21789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microloannexus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21789"}],"version-history":[{"count":1,"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/posts\/21789\/revisions"}],"predecessor-version":[{"id":21791,"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/posts\/21789\/revisions\/21791"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/media\/21790"}],"wp:attachment":[{"href":"https:\/\/microloannexus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microloannexus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microloannexus.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}